The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Functional Cure Drugs for Hepatitis B Market Research Report 2025
Synopsis
The global market for Functional Cure Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Functional Cure Drugs for Hepatitis B are a novel class of therapeutics designed to achieve functional cure in patients with chronic hepatitis B. Functional cure is defined as sustained loss of hepatitis B surface antigen (HBsAg), undetectable HBV DNA, improved liver inflammation and fibrosis, and no relapse after treatment cessation. Unlike conventional nucleos(t)ide analogs that only suppress viral replication, these drugs aim to eliminate or permanently silence the covalently closed circular DNA (cccDNA) of HBV and restore immune control. Current research focuses on direct-acting antivirals, immune modulators, and gene editing technologies. Successful development of such drugs would transform the treatment landscape for nearly 300 million chronic HBV patients worldwide, reducing the risk of cirrhosis and liver cancer.
North American market for Functional Cure Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Functional Cure Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Functional Cure Drugs for Hepatitis B in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Functional Cure Drugs for Hepatitis B include Arbutus Biopharma, GSK, Ascletis, Ausperbio, Janssen Biotech (Johnson & Johnson), Brii Biosciences, Barinthus Biotherapeutics, Suzhou Ribo Life Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Functional Cure Drugs for Hepatitis B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Cure Drugs for Hepatitis B.
The Functional Cure Drugs for Hepatitis B market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Functional Cure Drugs for Hepatitis B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Cure Drugs for Hepatitis B companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbutus Biopharma
GSK
Ascletis
Ausperbio
Janssen Biotech (Johnson & Johnson)
Brii Biosciences
Barinthus Biotherapeutics
Suzhou Ribo Life Science
Segment by Type
Antisense Oligonucleotide (ASO) Drugs
siRNA Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Functional Cure Drugs for Hepatitis B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Functional Cure Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Functional Cure Drugs for Hepatitis B are a novel class of therapeutics designed to achieve functional cure in patients with chronic hepatitis B. Functional cure is defined as sustained loss of hepatitis B surface antigen (HBsAg), undetectable HBV DNA, improved liver inflammation and fibrosis, and no relapse after treatment cessation. Unlike conventional nucleos(t)ide analogs that only suppress viral replication, these drugs aim to eliminate or permanently silence the covalently closed circular DNA (cccDNA) of HBV and restore immune control. Current research focuses on direct-acting antivirals, immune modulators, and gene editing technologies. Successful development of such drugs would transform the treatment landscape for nearly 300 million chronic HBV patients worldwide, reducing the risk of cirrhosis and liver cancer.
North American market for Functional Cure Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Functional Cure Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Functional Cure Drugs for Hepatitis B in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Functional Cure Drugs for Hepatitis B include Arbutus Biopharma, GSK, Ascletis, Ausperbio, Janssen Biotech (Johnson & Johnson), Brii Biosciences, Barinthus Biotherapeutics, Suzhou Ribo Life Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Functional Cure Drugs for Hepatitis B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Cure Drugs for Hepatitis B.
The Functional Cure Drugs for Hepatitis B market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Functional Cure Drugs for Hepatitis B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Cure Drugs for Hepatitis B companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbutus Biopharma
GSK
Ascletis
Ausperbio
Janssen Biotech (Johnson & Johnson)
Brii Biosciences
Barinthus Biotherapeutics
Suzhou Ribo Life Science
Segment by Type
Antisense Oligonucleotide (ASO) Drugs
siRNA Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Functional Cure Drugs for Hepatitis B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antisense Oligonucleotide (ASO) Drugs
1.2.3 siRNA Drugs
1.3 Market by Application
1.3.1 Global Functional Cure Drugs for Hepatitis B Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Functional Cure Drugs for Hepatitis B Market Perspective (2020-2031)
2.2 Global Functional Cure Drugs for Hepatitis B Growth Trends by Region
2.2.1 Global Functional Cure Drugs for Hepatitis B Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Functional Cure Drugs for Hepatitis B Historic Market Size by Region (2020-2025)
2.2.3 Functional Cure Drugs for Hepatitis B Forecasted Market Size by Region (2026-2031)
2.3 Functional Cure Drugs for Hepatitis B Market Dynamics
2.3.1 Functional Cure Drugs for Hepatitis B Industry Trends
2.3.2 Functional Cure Drugs for Hepatitis B Market Drivers
2.3.3 Functional Cure Drugs for Hepatitis B Market Challenges
2.3.4 Functional Cure Drugs for Hepatitis B Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Functional Cure Drugs for Hepatitis B Players by Revenue
3.1.1 Global Top Functional Cure Drugs for Hepatitis B Players by Revenue (2020-2025)
3.1.2 Global Functional Cure Drugs for Hepatitis B Revenue Market Share by Players (2020-2025)
3.2 Global Top Functional Cure Drugs for Hepatitis B Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Functional Cure Drugs for Hepatitis B Revenue
3.4 Global Functional Cure Drugs for Hepatitis B Market Concentration Ratio
3.4.1 Global Functional Cure Drugs for Hepatitis B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Functional Cure Drugs for Hepatitis B Revenue in 2024
3.5 Global Key Players of Functional Cure Drugs for Hepatitis B Head office and Area Served
3.6 Global Key Players of Functional Cure Drugs for Hepatitis B, Product and Application
3.7 Global Key Players of Functional Cure Drugs for Hepatitis B, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Functional Cure Drugs for Hepatitis B Breakdown Data by Type
4.1 Global Functional Cure Drugs for Hepatitis B Historic Market Size by Type (2020-2025)
4.2 Global Functional Cure Drugs for Hepatitis B Forecasted Market Size by Type (2026-2031)
5 Functional Cure Drugs for Hepatitis B Breakdown Data by Application
5.1 Global Functional Cure Drugs for Hepatitis B Historic Market Size by Application (2020-2025)
5.2 Global Functional Cure Drugs for Hepatitis B Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Functional Cure Drugs for Hepatitis B Market Size (2020-2031)
6.2 North America Functional Cure Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025)
6.4 North America Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Functional Cure Drugs for Hepatitis B Market Size (2020-2031)
7.2 Europe Functional Cure Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025)
7.4 Europe Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size (2020-2031)
8.2 Asia-Pacific Functional Cure Drugs for Hepatitis B Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size by Region (2020-2025)
8.4 Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Functional Cure Drugs for Hepatitis B Market Size (2020-2031)
9.2 Latin America Functional Cure Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025)
9.4 Latin America Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size (2020-2031)
10.2 Middle East & Africa Functional Cure Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025)
10.4 Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arbutus Biopharma
11.1.1 Arbutus Biopharma Company Details
11.1.2 Arbutus Biopharma Business Overview
11.1.3 Arbutus Biopharma Functional Cure Drugs for Hepatitis B Introduction
11.1.4 Arbutus Biopharma Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.1.5 Arbutus Biopharma Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Functional Cure Drugs for Hepatitis B Introduction
11.2.4 GSK Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Ascletis
11.3.1 Ascletis Company Details
11.3.2 Ascletis Business Overview
11.3.3 Ascletis Functional Cure Drugs for Hepatitis B Introduction
11.3.4 Ascletis Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.3.5 Ascletis Recent Development
11.4 Ausperbio
11.4.1 Ausperbio Company Details
11.4.2 Ausperbio Business Overview
11.4.3 Ausperbio Functional Cure Drugs for Hepatitis B Introduction
11.4.4 Ausperbio Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.4.5 Ausperbio Recent Development
11.5 Janssen Biotech (Johnson & Johnson)
11.5.1 Janssen Biotech (Johnson & Johnson) Company Details
11.5.2 Janssen Biotech (Johnson & Johnson) Business Overview
11.5.3 Janssen Biotech (Johnson & Johnson) Functional Cure Drugs for Hepatitis B Introduction
11.5.4 Janssen Biotech (Johnson & Johnson) Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.5.5 Janssen Biotech (Johnson & Johnson) Recent Development
11.6 Brii Biosciences
11.6.1 Brii Biosciences Company Details
11.6.2 Brii Biosciences Business Overview
11.6.3 Brii Biosciences Functional Cure Drugs for Hepatitis B Introduction
11.6.4 Brii Biosciences Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.6.5 Brii Biosciences Recent Development
11.7 Barinthus Biotherapeutics
11.7.1 Barinthus Biotherapeutics Company Details
11.7.2 Barinthus Biotherapeutics Business Overview
11.7.3 Barinthus Biotherapeutics Functional Cure Drugs for Hepatitis B Introduction
11.7.4 Barinthus Biotherapeutics Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.7.5 Barinthus Biotherapeutics Recent Development
11.8 Suzhou Ribo Life Science
11.8.1 Suzhou Ribo Life Science Company Details
11.8.2 Suzhou Ribo Life Science Business Overview
11.8.3 Suzhou Ribo Life Science Functional Cure Drugs for Hepatitis B Introduction
11.8.4 Suzhou Ribo Life Science Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025)
11.8.5 Suzhou Ribo Life Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antisense Oligonucleotide (ASO) Drugs
Table 3. Key Players of siRNA Drugs
Table 4. Global Functional Cure Drugs for Hepatitis B Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Functional Cure Drugs for Hepatitis B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Functional Cure Drugs for Hepatitis B Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Functional Cure Drugs for Hepatitis B Market Share by Region (2020-2025)
Table 8. Global Functional Cure Drugs for Hepatitis B Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Functional Cure Drugs for Hepatitis B Market Share by Region (2026-2031)
Table 10. Functional Cure Drugs for Hepatitis B Market Trends
Table 11. Functional Cure Drugs for Hepatitis B Market Drivers
Table 12. Functional Cure Drugs for Hepatitis B Market Challenges
Table 13. Functional Cure Drugs for Hepatitis B Market Restraints
Table 14. Global Functional Cure Drugs for Hepatitis B Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Functional Cure Drugs for Hepatitis B Market Share by Players (2020-2025)
Table 16. Global Top Functional Cure Drugs for Hepatitis B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Cure Drugs for Hepatitis B as of 2024)
Table 17. Ranking of Global Top Functional Cure Drugs for Hepatitis B Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Functional Cure Drugs for Hepatitis B Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Functional Cure Drugs for Hepatitis B, Headquarters and Area Served
Table 20. Global Key Players of Functional Cure Drugs for Hepatitis B, Product and Application
Table 21. Global Key Players of Functional Cure Drugs for Hepatitis B, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Functional Cure Drugs for Hepatitis B Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Functional Cure Drugs for Hepatitis B Revenue Market Share by Type (2020-2025)
Table 25. Global Functional Cure Drugs for Hepatitis B Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Functional Cure Drugs for Hepatitis B Revenue Market Share by Type (2026-2031)
Table 27. Global Functional Cure Drugs for Hepatitis B Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Functional Cure Drugs for Hepatitis B Revenue Market Share by Application (2020-2025)
Table 29. Global Functional Cure Drugs for Hepatitis B Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Functional Cure Drugs for Hepatitis B Revenue Market Share by Application (2026-2031)
Table 31. North America Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 46. Arbutus Biopharma Company Details
Table 47. Arbutus Biopharma Business Overview
Table 48. Arbutus Biopharma Functional Cure Drugs for Hepatitis B Product
Table 49. Arbutus Biopharma Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 50. Arbutus Biopharma Recent Development
Table 51. GSK Company Details
Table 52. GSK Business Overview
Table 53. GSK Functional Cure Drugs for Hepatitis B Product
Table 54. GSK Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Ascletis Company Details
Table 57. Ascletis Business Overview
Table 58. Ascletis Functional Cure Drugs for Hepatitis B Product
Table 59. Ascletis Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 60. Ascletis Recent Development
Table 61. Ausperbio Company Details
Table 62. Ausperbio Business Overview
Table 63. Ausperbio Functional Cure Drugs for Hepatitis B Product
Table 64. Ausperbio Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 65. Ausperbio Recent Development
Table 66. Janssen Biotech (Johnson & Johnson) Company Details
Table 67. Janssen Biotech (Johnson & Johnson) Business Overview
Table 68. Janssen Biotech (Johnson & Johnson) Functional Cure Drugs for Hepatitis B Product
Table 69. Janssen Biotech (Johnson & Johnson) Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 70. Janssen Biotech (Johnson & Johnson) Recent Development
Table 71. Brii Biosciences Company Details
Table 72. Brii Biosciences Business Overview
Table 73. Brii Biosciences Functional Cure Drugs for Hepatitis B Product
Table 74. Brii Biosciences Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 75. Brii Biosciences Recent Development
Table 76. Barinthus Biotherapeutics Company Details
Table 77. Barinthus Biotherapeutics Business Overview
Table 78. Barinthus Biotherapeutics Functional Cure Drugs for Hepatitis B Product
Table 79. Barinthus Biotherapeutics Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 80. Barinthus Biotherapeutics Recent Development
Table 81. Suzhou Ribo Life Science Company Details
Table 82. Suzhou Ribo Life Science Business Overview
Table 83. Suzhou Ribo Life Science Functional Cure Drugs for Hepatitis B Product
Table 84. Suzhou Ribo Life Science Revenue in Functional Cure Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 85. Suzhou Ribo Life Science Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Functional Cure Drugs for Hepatitis B Picture
Figure 2. Global Functional Cure Drugs for Hepatitis B Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Functional Cure Drugs for Hepatitis B Market Share by Type: 2024 VS 2031
Figure 4. Antisense Oligonucleotide (ASO) Drugs Features
Figure 5. siRNA Drugs Features
Figure 6. Global Functional Cure Drugs for Hepatitis B Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Functional Cure Drugs for Hepatitis B Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Functional Cure Drugs for Hepatitis B Report Years Considered
Figure 12. Global Functional Cure Drugs for Hepatitis B Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Functional Cure Drugs for Hepatitis B Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Functional Cure Drugs for Hepatitis B Market Share by Region: 2024 VS 2031
Figure 15. Global Functional Cure Drugs for Hepatitis B Market Share by Players in 2024
Figure 16. Global Functional Cure Drugs for Hepatitis B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Functional Cure Drugs for Hepatitis B Revenue in 2024
Figure 18. North America Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Functional Cure Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 20. United States Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Functional Cure Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 24. Germany Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Functional Cure Drugs for Hepatitis B Market Share by Region (2020-2031)
Figure 32. China Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Functional Cure Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 40. Mexico Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Functional Cure Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 44. Turkey Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Functional Cure Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Arbutus Biopharma Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 48. GSK Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 49. Ascletis Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 50. Ausperbio Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 51. Janssen Biotech (Johnson & Johnson) Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 52. Brii Biosciences Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 53. Barinthus Biotherapeutics Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 54. Suzhou Ribo Life Science Revenue Growth Rate in Functional Cure Drugs for Hepatitis B Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
